AMGEN INC — Director's Dealing 2014

Aug 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2014-08-05

Reporting Person: de Carbonnel Francois (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-05	Common Stock	M	5000	$54.69	Acquired	24620	Direct
2014-08-05	Common Stock	F	2471	$128.65	Disposed	22149	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-05	Nqso (Right to Buy)	$54.69	M	5000	Disposed	2021-04-25	Common Stock (5000)	Direct

Footnotes

F1: These shares include 116 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.